dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Grignani, Giovanni |
dc.contributor.author | Martínez-Trufero, Javier |
dc.contributor.author | Redondo Sanchez, Andres |
dc.contributor.author | Valverde Morales, Claudia Maria |
dc.contributor.author | Martin-Broto, Javier |
dc.contributor.author | Hindi, Nadia |
dc.date.accessioned | 2021-10-19T10:06:42Z |
dc.date.available | 2021-10-19T10:06:42Z |
dc.date.issued | 2020-11 |
dc.identifier.citation | Martin-Broto J, Hindi N, Grignani G, Martinez-Trufero J, Redondo A, Valverde C, et al. Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial. J Immunother Cancer. 2020;8(2):e001561. |
dc.identifier.issn | 2051-1426 |
dc.identifier.uri | https://hdl.handle.net/11351/6405 |
dc.description | Immunoteràpia; Sarcoma; Investigació mèdica translacional |
dc.description.sponsorship | This work was supported by GEIS and ISG. BMS and Pfizer provided drug supply and partial funding for shipping. Translational studies were partially funded by Beca Buesa from the GEIS group. |
dc.language.iso | eng |
dc.publisher | BMJ Publishing Group |
dc.relation.ispartofseries | Journal for ImmunoTherapy of Cancer;8(2) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Sarcoma - Tractament |
dc.subject | Càncer - Immunoteràpia |
dc.subject.mesh | Sarcoma |
dc.subject.mesh | Antineoplastic Agents, Immunological |
dc.title | Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/jitc-2020-001561 |
dc.subject.decs | sarcoma |
dc.subject.decs | inmunoterapia antineoplásica |
dc.relation.publishversion | http://dx.doi.org/10.1136/jitc-2020-001561 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Martin-Broto J, Hindi N] Medical Oncology Department, University Hospital Virgen del Rocio, Sevilla, Spain. Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain. [Grignani G] Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS - Str. Prov.le 142, km. 3,95 - Candiolo (TO) 10060, Candiolo, Italy. [Martinez-Trufero J] Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain. [Redondo A] Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. [Valverde C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 33203665 |
dc.identifier.wos | 000599997700001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |